REDWOOD CITY, Calif., Nov. 11, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for ...
REDWOOD CITY, Calif., May 20, 2025 /PRNewswire/ -- A new publication featuring Aliya® PEF has been published in the Journal of Surgical Oncology. This publication features the INCITE-ES study, which ...
New clinical data published in Clinical Cancer Research, together with independent recognition in Nature Cancer, suggest Aliya PEF may help create an organized immune response within tumors, adding to ...
Newswise — REDWOOD CITY, Calif., Aug. 11, 2026 -- Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic ...
Next-generation generator delivers up to a 7x increase in ablation volume while preserving the core benefits of Aliya PEF energy REDWOOD CITY, Calif., May 18, 2026 /PRNewswire/ -- Galvanize ...
REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed ...
REDWOOD CITY, Calif. , Sept. 20, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc. today announced the treatment of the first patient in the AFFINITY clinical study. This prospective trial is intended ...
Six-month results from U.S. clinical study show promise for the innovative technology in patients with stage IV non-small cell lung cancer or lung metastasis REDWOOD CITY, Calif., Nov. 11, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results